References
- Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA (2012). First-line chemotherapy in low-risk gestational trophoblastic neoplasia. Cochrane Database Syst Rev, 7, 7102.
- Aydiner A, Keskin S, Berkman S, et al (2012). The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia. J Cancer Res Clin Oncol, 138, 971-7. https://doi.org/10.1007/s00432-012-1173-7
- Berkowitz RS, Goldstein DP (1996). Chorionic tumors. N Engl J Med, 335, 1740-8. https://doi.org/10.1056/NEJM199612053352306
- Berkowitz RS, Goldstein DP (2009). Current management of gestational trophoblasticdiseases. Gynecol Oncol, 112, 654-62. https://doi.org/10.1016/j.ygyno.2008.09.005
- Deng L, Yan X, Zhang J, Wu T (2009). Combination chemotherapy for high-risk gestational trophoblastic tumour. Cochrane Database Syst Rev, 2, 5196.
- Gul T, Yilmaztürk A, Erden AC (1997). A review of trophoblastic diseases at the medical school of Dicle University. Eur J Obstet Gynecol Reprod Biol, 74, 37-40. https://doi.org/10.1016/S0301-2115(97)00071-7
- Harma M, Harma M, Yurtseven S, Gungen N (2005). Gestational trophoblastic disease in Sanliurfa, southeast Anatolia, Turkey. Eur J Gynaecol Oncol, 26, 306-8.
- Kingdon SJ, Coleman RE, Ellis L, Hancock BW (2012). Deaths from gestational trophoblastic neoplasia: any lessons to be learned? J Reprod Med, 57, 293-6.
- Kurdoglu M, Kurdoglu Z, Kucukaydin Z, Sahin HG, Kamaci M (2011). Gestational trophoblastic diseases: Fourteen year experience of our clinic. J Turk Soc Obstet Gynecol, 8, 134-9. https://doi.org/10.5505/tjod.2011.98470
- Lurain JR (2011). Gestational trophoblastic disease II:classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol, 204, 11-8. https://doi.org/10.1016/j.ajog.2010.06.072
- Manopunya M, Suprasert P (2012). Resistant gestational trophoblastic neoplasia patients treated with 5-fluorouracil plus actinomycin D. Asian Pac J Cancer Prev, 13, 387-90. https://doi.org/10.7314/APJCP.2012.13.1.387
- May T, Goldstein DP, Berkowitz RS (2011). Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract, 2011, 806256.
- Oranratanaphan S, Lertkhachonsuk R (2014). Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in king chulalongkorn memorial hospital. Asian Pac J Cancer Prev, 15, 925-8. https://doi.org/10.7314/APJCP.2014.15.2.925
- Ozalp SS, Yalçin OT, Tanir HM (2001). A hospital-based multicentric study results on gestational trophoblastic disease management status in a developing country. Eur J Gynaecol Oncol, 22, 221-2.
- Ozalp SS, Oge T (2013). Gestational trophoblastic diseases in Turkey. J Reprod Med, 58, 67-71.
- Pongsaranantakul S, Kietpeerakool C (2009). Hysterectomy in gestational trophoblastic neoplasia: Chiang Mai university hospital's experience. Asian Pac J Cancer Prev, 10, 311-4.
- Turan T, Karacay O, Tulunay G, et al (2006). Results with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia. Int J Gynecol Cancer, 16, 1432-8. https://doi.org/10.1111/j.1525-1438.2006.00606.x
Cited by
- Quality of Life in Gestational Trophoblastic Neoplasia Patients after Treatment in Thailand vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10871
- Outcomes of Non-Metastatic Gestational Trophoblastic Neoplasia: Twelve Year Experience from a Northern Thailand Tertiary Care Center vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5913
- Malignancy Risk Scoring of Hydatidiform Moles vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2441
- Epidemiology of Hydatidiform Moles in a Tertiary Hospital in Thailand over Two Decades: Impact of the National Health Policy vol.16, pp.18, 2015, https://doi.org/10.7314/APJCP.2015.16.18.8321
- Clinical Characteristics of Gestational Trophoblastic Neoplasia vol.26, pp.1, 2016, https://doi.org/10.1097/IGC.0000000000000570
- Historical, morphological and clinical overview of placental site trophoblastic tumors: from bench to bedside vol.295, pp.1, 2017, https://doi.org/10.1007/s00404-016-4182-y